John J. Normile

Jones Day
New York

Practice Area: IP & IP Litigation

BTI Client Service All Star History
  • 2015
  • 2019
All Star


“John understands us deeply.”
“He is always cognizant of thinking about what is critically important to our business.”


"I am both professionally and personally proud of the fact that I have existing client relationships that have spanned multiple decades. I believe the key to a successful client relationship is to truly get to know your client and their business from top to bottom and to be fully attuned to their short term and long term legal and business objectives not only in your practice area but in all areas. I also believe it is essential to be responsive to your client’s needs and to seek out and meaningfully act on client feedback."

– John J. Normile


John Normile is a leading Hatch-Waxman patent litigator who has 30 years experience representing innovative pharmaceutical companies. He also has represented various plaintiffs and defendants in intellectual property cases involving diverse technologies. Among the clients for whom he has worked are Bic, Fenwal, King Pharmaceuticals, Merck, Purdue Pharma L.P., and Schweitzer-Mauduit.

John has acted as trial counsel before several of the federal district and appellate courts including the Federal Circuit and the U.S. Supreme Court. He has represented pharmaceutical companies in the enforcement of patents concerning blockbuster drugs including OxyContin®, Butrans®, Hysingla®, Skelaxin®, Buspar®, and MitomycinC®. John also has experience representing clients as lead counsel in USPTO post-grant proceedings. These representations have involved at least 50 district court actions and various appearances in the USPTO and the Federal Circuit. John is an adjunct professor at Fordham Law School, where he has taught a course in patent litigation for the past 20 years.

His clients have consistently praised his approach to Hatch-Waxman cases: “John is brilliant at creating and executing great litigation strategies. He makes complicated matters simple and takes a comprehensive approach that goes beyond patent law to accomplish the goals of his clients. He’s one of the best litigators for complex pharmaceutical matters.” (IAM Patent 1000: The World’s Leading Patent Professionals (2018)).

John is a member of the President’s Council and the Parent Leadership Council at Fordham University, the Fordham Law School Alumni Association, the Feerick Institute of Social Justice, and the New York Archdiocese Inner-City Scholarship Fund.

Visit All Star's Firm »